Journal Title：Experimental And Molecular Pathology

Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.

Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.

在新的編輯領導下，《實驗與分子病理學》刊登了關于與哺乳動物組織和體液的結構和生化變化有關的疾病過程的原創(chuàng)文章，以及關于將分子生物學的新技術應用于人類和其他動物的病理學問題的原創(chuàng)文章。該雜志還發(fā)表了由在當代病理學研究“前沿”工作的實驗室級研究人員撰寫的精選解釋性綜合評論。此外，特別專題刊登了原創(chuàng)研究報告，揭示了自然界關于疾病病理基礎的一些最嚴加保守的秘密。

研究領域包括：干細胞；新血管生成；分子診斷；聚合酶鏈反應；原位雜交；DNA測序；細胞受體；致癌作用；腫瘤病理生物學；復雜傳染??；移植；細胞因子；流式細胞分析；炎癥；細胞損傷；免疫學和超敏反應；動脈粥樣硬化。

Experimental And Molecular Pathology創(chuàng)刊于1962年，由Academic Press Inc.出版商出版，收稿方向涵蓋醫(yī)學 - 病理學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 約4.5月 約11.5周，影響因子指數2.8，該期刊近期被列入國際期刊預警名單，請廣大學者慎重選擇。